These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8272722)

  • 41. [Immunologic and insulin secretion markers in non insulin dependent diabetic patients with secondary failure to oral hypoglycemic drugs].
    Maiz A; Manrique M; Arteaga A; Acosta AM; Andrade L
    Rev Med Chil; 1995 Oct; 123(10):1199-203. PubMed ID: 8733310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Combined treatment of insulin and GLP-1 analogs: what do we expect?].
    de Kalbermatten B; Jaafar J; Jornayvaz FR; Philippe J
    Rev Med Suisse; 2014 Jun; 10(433):1235-6, 1238-40. PubMed ID: 25004768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bedtime intermediate-acting insulin in the treatment of secondary failure to oral hypoglycemic agents.
    Chuang LM; Lu C; Su RJ; Wu HP; Tai TY; Lin BJ
    J Formos Med Assoc; 1992 Feb; 91(2):185-9. PubMed ID: 1364216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ATP-sensitive K+ channels and insulin secretion: their role in health and disease.
    Ashcroft FM; Gribble FM
    Diabetologia; 1999 Aug; 42(8):903-19. PubMed ID: 10491749
    [No Abstract]   [Full Text] [Related]  

  • 48. [Insulin and oral antidiabetic drugs. How to combine them in type 2 diabetes?].
    Lotz N
    MMW Fortschr Med; 2000 May; 142(18):45-8. PubMed ID: 10851870
    [No Abstract]   [Full Text] [Related]  

  • 49. [How to prescribe oral hypoglycemic agents].
    Sakura H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():317-24. PubMed ID: 12387012
    [No Abstract]   [Full Text] [Related]  

  • 50. [Delayed action of oral antidiabetic treatments. Place of combination of insulin and hypoglycemic sulfamides].
    Leutenegger M; Nakib Y; Grulet H; Gross A; Boirie Y
    Journ Annu Diabetol Hotel Dieu; 1993; ():97-114. PubMed ID: 8331877
    [No Abstract]   [Full Text] [Related]  

  • 51. Type 2 diabetes mellitus: an evolving therapeutic approach.
    McElduff A
    P N G Med J; 2001; 44(3-4):124-30. PubMed ID: 12422983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Drug therapy of type-II diabetes: tablets, insulin or a combination of these].
    Diem P
    Schweiz Rundsch Med Prax; 1994 Jan; 83(3):68-71. PubMed ID: 8296132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Early control of diabetic sequelae. Combined insulin treatment also in type 2].
    MMW Fortschr Med; 2000 Jun; 142(25):57. PubMed ID: 10920674
    [No Abstract]   [Full Text] [Related]  

  • 54. [Combination therapy of oral hypoglycemic agents which enhance the efficacy of insulin therapy].
    Hirose T
    Nihon Rinsho; 2012 May; 70 Suppl 3():669-77. PubMed ID: 22768596
    [No Abstract]   [Full Text] [Related]  

  • 55. [Renewal of oral therapy for diabetes mellitus after secondary failure].
    Guberman D
    Harefuah; 1989 Nov; 117(9):240-1. PubMed ID: 2693275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuation of oral medications when insulin is initiated.
    Neumiller JJ; Setter SM
    South Med J; 2010 Jan; 103(1):7-8. PubMed ID: 19996859
    [No Abstract]   [Full Text] [Related]  

  • 57. Present recommendations in type 2 diabetes treatment.
    Lebovitz HE
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():46-9. PubMed ID: 20629232
    [No Abstract]   [Full Text] [Related]  

  • 58. Type 2 diabetes: to stimulate or not to stimulate the beta cell.
    Cerasi E
    Metabolism; 2000 Oct; 49(10 Suppl 2):1-2. PubMed ID: 11078467
    [No Abstract]   [Full Text] [Related]  

  • 59. Sitagliptin and metformin--novel combination therapy.
    Seyoum B
    Expert Opin Pharmacother; 2011 Mar; 12(4):641-6. PubMed ID: 21291346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New Insulin Options for Diabetic Patients.
    Van Klompenburg E; Heins JR
    S D Med; 2016 Feb; 69(2):84-5. PubMed ID: 26999916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.